Luteolin Reduces Inflammation in Endothelial Cells
Author Information
Author(s): Qing-Yu Lu, Li Guo, Qi-Yun Zhang, Fu-Mei Yang, Shu-Ting Zhou, Qian-Yun Sun
Primary Institution: Guizhou Medical University
Hypothesis
This study aims to investigate the effects and mechanisms of luteolin on TNF-α-induced inflammatory injury in human microvascular endothelial cells.
Conclusion
Luteolin effectively suppresses TNF-α-induced inflammatory injury in endothelial cells via the Akt/MAPK/NF-κB pathway.
Supporting Evidence
- Luteolin treatment significantly reduced the expression of proinflammatory cytokines ICAM-1, IL-6, IL-8, and MCP-1.
- Luteolin inhibited the phosphorylation of NF-κB p65, MAPK, and Akt signaling pathways.
- Treatment with luteolin resulted in decreased transcriptional activity of NF-κB and AP-1.
Takeaway
Luteolin is a natural compound that helps reduce inflammation in blood vessel cells, which can be important for heart health.
Methodology
The study used human microvascular endothelial cells treated with TNF-α and varying concentrations of luteolin to assess inflammatory responses through various assays including ELISA and western blot.
Limitations
The study primarily focused on microvascular endothelial cells, and the findings may not be generalizable to other cell types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website